Score:   1
Docket Number:   MD-PA  3:20-cr-00112
Case Name:   USA v. Natural Advantage LLC
  Press Releases:
SCRANTON – The United States Attorney’s Office for the Middle District of Pennsylvania announced today that Natural Advantage LLC a/k/a Taste Advantage LLC (“Natural Advantage”), a chemical manufacturer headquartered in Oakdale, Louisiana, entered a deferred prosecution agreement and was charged in a criminal information with the unregistered distribution and exportation of regulated List 1 chemicals.  Carol Callahan Byrne, age 65, and Dr. Brian Byrne, age 74, both of Oakdale, Louisiana, also were charged in a criminal information with the failure to report List 1 chemical manufacturing to the Attorney General.

Natural Advantage entered a three-year deferred prosecution agreement, under which the United States has agreed to defer prosecution of the company unless it fails to comply with the terms of the agreement.  Pursuant to the deferred prosecution agreement, Natural Advantage has agreed to forfeit $1,938,650.10, which represents the gross revenue of its List 1 chemical sales.  The company also has agreed, among other things, to undergo annual audits for List 1 chemical compliance, the results of which will be reported to the United States.

According to United States Attorney David J. Freed, Carol Callahan Byrne served as the Chief Financial Officer and Dr. Brian Byrne served as the Chief Executive Officer of Natural Advantage, a company that manufactured chemicals for customers in the flavor, fragrance, and cosmetics industries.  Among the chemicals manufactured by Natural Advantage were Piperonal, Heliotropine, Phenylacetic Acid, Isoamyl Phenylacetate, and Ethyl Phenylacetate, all of which were List 1 chemicals that, in addition to legitimate uses, are also precursor chemicals for manufacturing methamphetamine and ecstasy.  List 1 chemicals are subject to extensive regulations, including licensing requirements for distributors and regular reporting to the United States.

As alleged, beginning in approximately January 2011, and continuing until January 2017, Natural Advantage distributed and exported in excess of 1,550 kilograms of List 1 chemicals to customers in the United States and worldwide, without obtaining the requisite registration from the U.S. Drug Enforcement Administration (DEA), and despite being warned by the DEA not to distribute List 1 chemicals.  None of the chemicals are alleged to have been diverted to narcotics traffickers.

Company executives are alleged to have known of Natural Advantage’s unlicensed distribution of List 1 chemicals, and of arrangements to use other domestic companies as intermediaries to sell List 1 chemicals to foreign customers who discovered that Natural Advantage was not licensed and refused to purchase the chemicals.  Company executives also are alleged to have concealed Natural Advantage’s List 1 chemical activities, including, as alleged against Carol Callahan Byrne and Dr. Brian Byrne, by failing to file annual manufacturing reports with the Attorney General.

“The defendants in this case violated the law when they sold and exported nearly $2 million-worth of precursor chemicals, without following the regulations and procedures designed to ensure that these chemicals do not end up on the black market,” said U.S. Attorney Freed. “As part of our responsibility to help protect the public from dangerous drugs, this office will continue to ensure that companies properly handle List I chemicals.”

“By intentionally evading the regulations in place for List I chemicals, Natural Advantage greatly increased the possibility that these chemicals could end up in the hands of cartels for the production of methamphetamine, ecstasy, and other dangerous and illicit substances,” said Jonathan A. Wilson, Special Agent in Charge of the DEA’s Philadelphia Field Division.  “In light of the rise of methamphetamine use in the United States and the damage it causes to our families and our society, DEA will continue to enforce these regulations and seek out these violators.”

The case was investigated by DEA Diversion Investigators. Assistant U.S. Attorney Phillip J. Caraballo, and the Financial Litigation Unit of the U.S. Attorney’s Office are prosecuting the case.

Criminal informations are only allegations. All persons charged are presumed to be innocent unless and until found guilty in court.

A sentence following a finding of guilt is imposed by the Judge after consideration of the applicable federal sentencing statutes and the Federal Sentencing Guidelines.

The maximum penalty under federal law for the charge against Natural Advantage is up to five years of probation, and the maximum penalties for the charges against Carol Callahan Byrne and Brian Byrne are up to one year of imprisonment, a term of supervised release following imprisonment, and a fine. Under the Federal Sentencing Guidelines, the Judge is also required to consider and weigh a number of factors, including the nature, circumstances and seriousness of the offense; the history and characteristics of the defendant; and the need to punish the defendant, protect the public and provide for the defendant's educational, vocational and medical needs. For these reasons, the statutory maximum penalty for the offense is not an accurate indicator of the potential sentence for a specific defendant.

 

# # #

Description: The fiscal year of the data file obtained from the AOUSC
Format: YYYY

Description: The code of the federal judicial circuit where the case was located
Format: A2

Description: The code of the federal judicial district where the case was located
Format: A2

Description: The code of the district office where the case was located
Format: A2

Description: Docket number assigned by the district to the case
Format: A7

Description: A unique number assigned to each defendant in a case which cannot be modified by the court
Format: A3

Description: A unique number assigned to each defendant in a case which can be modified by the court
Format: A3

Description: A sequential number indicating whether a case is an original proceeding or a reopen
Format: N5

Description: Case type associated with the current defendant record
Format: A2

Description: A concatenation of district, office, docket number, case type, defendant number, and reopen sequence number
Format: A18

Description: A concatenation of district, office, docket number, case type, and reopen sequence number
Format: A15

Description: The status of the defendant as assigned by the AOUSC
Format: A2

Description: A code indicating the fugitive status of a defendant
Format: A1

Description: The date upon which a defendant became a fugitive
Format: YYYYMMDD

Description: The date upon which a fugitive defendant was taken into custody
Format: YYYYMMDD

Description: The date when a case was first docketed in the district court
Format: YYYYMMDD

Description: The date upon which proceedings in a case commenced on charges pending in the district court where the defendant appeared, or the date of the defendant’s felony-waiver of indictment
Format: YYYYMMDD

Description: A code used to identify the nature of the proceeding
Format: N2

Description: The date when a defendant first appeared before a judicial officer in the district court where a charge was pending
Format: YYYYMMDD

Description: A code indicating the type of legal counsel assigned to a defendant
Format: N2

Description: The title and section of the U.S. Code applicable to the offense committed which carried the highest severity
Format: A20

Description: A code indicating the level of offense associated with FTITLE1
Format: N2

Description: The four digit AO offense code associated with FTITLE1
Format: A4

Description: The four digit D2 offense code associated with FTITLE1
Format: A4

Description: A code indicating the severity associated with FTITLE1
Format: A3

Description: The FIPS code used to indicate the county or parish where an offense was committed
Format: A5

Description: The date of the last action taken on the record
Format: YYYYMMDD

Description: The date upon which judicial proceedings before the court concluded
Format: YYYYMMDD

Description: The date upon which the final sentence is recorded on the docket
Format: YYYYMMDD

Description: The date upon which the case was closed
Format: YYYYMMDD

Description: The total fine imposed at sentencing for all offenses of which the defendant was convicted and a fine was imposed
Format: N8

Description: A count of defendants filed including inter-district transfers
Format: N1

Description: A count of defendants filed excluding inter-district transfers
Format: N1

Description: A count of original proceedings commenced
Format: N1

Description: A count of defendants filed whose proceedings commenced by reopen, remand, appeal, or retrial
Format: N1

Description: A count of defendants terminated including interdistrict transfers
Format: N1

Description: A count of defendants terminated excluding interdistrict transfers
Format: N1

Description: A count of original proceedings terminated
Format: N1

Description: A count of defendants terminated whose proceedings commenced by reopen, remand, appeal, or retrial
Format: N1

Description: A count of defendants pending as of the last day of the period including long term fugitives
Format: N1

Description: A count of defendants pending as of the last day of the period excluding long term fugitives
Format: N1

Description: The source from which the data were loaded into the AOUSC’s NewSTATS database
Format: A10

Description: A sequential number indicating the iteration of the defendant record
Format: N2

Description: The date the record was loaded into the AOUSC’s NewSTATS database
Format: YYYYMMDD

Description: Statistical year ID label on data file obtained from the AOUSC which represents termination year
Format: YYYY

Data imported from FJC Integrated Database
F U C K I N G P E D O S R E E E E E E E E E E E E E E E E E E E E